BluGlass Limited (ASX:BLG) Puts Gallium Nitride Laser Commercialisation in Focus

Aditi Sarkar

11 November 2026 04:33 PM AEDT

BluGlass Limited (ASX:BLG) Puts Gallium Nitride Laser Commercialisation in Focus

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

• BluGlass continues developing gallium nitride lasers and related semiconductor materials through its specialist technology platform.

• The company reported FY26 Revenue of approximately AUD 10.5 million and a narrower annual net loss.

• Trading Volume remained below its recent average as shares changed hands around 18 cents intraday.

• Recent company notices concerned securities and directors’ interests rather than a new price-sensitive operational announcement.

The development of gallium nitride lasers remains central to BluGlass Limited (ASX:BLG), even as its latest share-price movement arrived without a new price-sensitive announcement. The semiconductor developer is pursuing commercial applications for its technology against a backdrop of light trading and continuing Investment in product development.

Laser Technology at the Centre

BluGlass develops and commercialises gallium nitride materials and devices. Its technology work includes a low-temperature Manufacturing process described as remote plasma chemical vapour deposition, although the available account flags the process description for verification. The company’s development efforts centre on gallium nitride lasers and related materials. Omer Granit serves as executive chair, while Jim Haden is managing director.

A Quiet Announcement Calendar

No company release was recorded for 10 or 11 November 2026. The recent filing sequence included a change of director’s interest notice around 2 November, followed by a cleansing notice, an application to quote securities and a notification concerning unquoted securities on 30 October. These filings did not establish a Business catalyst for the session’s share-price movement.

Revenue, Losses and Capital

Revenue for FY26 was approximately AUD 10.5 million, compared with about AUD 11.7 million in FY25. The annual net loss narrowed to around AUD 10.4 million from roughly AUD 11.0 million. BluGlass had approximately 193 million shares issued and a Market Value of about AUD 33 million at the previous closing price. Its 52-week trading range stretched from 16.5 cents to 55 cents.

Commercial Execution Remains the Focus

BluGlass has relied on Capital raising and funding arrangements to support its work. Commercial uptake will depend on product reliability, customer qualification and manufacturing capacity. Around 2:40pm AEDT on 11 November, shares traded near 18 cents, against a prior close of 17 cents. Approximately 65,000 shares changed hands, below the recent daily average of roughly 242,000. No dated future milestone was confirmed in the available information.

FAQs

Q: What technology does BluGlass develop?

A: Gallium nitride lasers, semiconductor materials and related devices.

Q: What revenue did BluGlass report for FY26?

A: Approximately AUD 10.5 million.

Q: Was there a new announcement on 11 November?

A: The available information records no company release on 10 or 11 November 2026.

Q: Who leads BluGlass?

A: Omer Granit is executive chair and Jim Haden is managing director.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.